Clearmind Medicine - Common Shares (CMND) closed at $6.22 on October 30, 2026, up 6.3% from the previous close, on volume of 10,203 shares (30-day average 61,656).
Data as of October 30, 2026.
Globe Newswire (Tue, 27-Oct 8:22 AM ET)
Globe Newswire (Mon, 12-Oct 7:55 AM ET)
Globe Newswire (Thu, 8-Oct 7:32 AM ET)
Globe Newswire (Wed, 7-Oct 8:40 AM ET)
Globe Newswire (Wed, 23-Sep 8:35 AM ET)
Globe Newswire (Wed, 23-Sep 7:57 AM ET)
Globe Newswire (Thu, 17-Sep 7:42 AM ET)
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Globe Newswire (Fri, 11-Sep 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 7:42 AM ET)
Globe Newswire (Fri, 4-Sep 7:32 AM ET)
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Clearmind Medicine - Common Shares trades on the NASDAQ stock market under the symbol CMND.
As of October 30, 2026, CMND stock price climbed to $6.22 with 10,203 million shares trading.
CMND has a beta of 2.27, meaning it tends to be more sensitive to market movements. CMND has a correlation of 0.01 to the broad based SPY ETF.
CMND has a market cap of $3.16 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CMND traded as high as $2,720.00 and as low as $.71.
CMND has underperformed the market in the last year with a return of -98.3%, while SPY returned +12.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CMND shares. However, CMND has outperformed the market in the last 3 month and 2 week periods, returning +283.9% and -0.7%, while SPY returned +2.1% and -1.0%, respectively. This indicates CMND has been having a stronger performance recently.
CMND support price is $5.31 and resistance is $6.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMND shares will trade within this expected range on the day.
